Načítá se...
From Pharmacovigilance to Clinical Care Optimization
In order to ensure the continued, safe administration of pharmaceuticals, particularly those agents that have been recently introduced into the market, there is a need for improved surveillance after product release. This is particularly so because drugs are used by a variety of patients whose parti...
Uloženo v:
| Vydáno v: | Big Data |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc.
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4630790/ https://ncbi.nlm.nih.gov/pubmed/26576325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/big.2014.0008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|